Shoulder Innovations (SI) CFO exercises options and buys additional shares

Rhea-AI Filing Summary

SHOULDER INNOVATIONS, INC. Chief Financial Officer Jeffrey S. Points increased his stake through option exercises and a share purchase. On March 13, 2026, he exercised stock options to acquire 13,264 shares of common stock at $2.4804 per share, converting a derivative position into stock. He also made an open-market purchase of 2,000 common shares at $15.00 per share the same day. Following these transactions, he holds 70,785 common shares directly and 50 shares indirectly held by his son. The exercised option was part of a grant that vests in 31 equal monthly increments beginning on March 31, 2025.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Points Jeffrey S.

(Last) (First) (Middle)

C/O SHOULDER INNOVATIONS, INC.

1535 STEELE AVENUE SW, SUITE B

(Street)

GRAND RAPIDS MI 49507

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SHOULDER INNOVATIONS, INC. [ SI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/13/2026		M		13,264	A	$2.4804	68,785	D
Common Stock	03/13/2026		P		2,000	A	$15	70,785	D
Common Stock								50	I	By son

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$2.4804	03/13/2026		M			13,264	(1)	11/16/2033	Common Stock	13,264	$0	42,004	D

Explanation of Responses:

1. The stock option vests in 31 equal increments on the last day of each calendar month beginning on March 31, 2025.

Remarks:

	/s/ Jeffrey S. Points	03/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did SHOULDER INNOVATIONS (SI) report for its CFO?

The CFO, Jeffrey S. Points, exercised stock options for 13,264 shares at $2.4804 and bought 2,000 common shares at $15.00 on March 13, 2026, increasing his direct ownership.

How many SHOULDER INNOVATIONS (SI) shares does the CFO own after these transactions?

After the transactions, the CFO directly owns 70,785 common shares and indirectly owns 50 shares held by his son. These figures reflect his total reported position immediately following the March 13, 2026 activity.

What type of derivative security did the SHOULDER INNOVATIONS (SI) CFO exercise?

He exercised a stock option covering 13,264 underlying common shares at an exercise price of $2.4804 per share. This converted his option position into actual common stock on March 13, 2026.

Was there an open-market purchase by SHOULDER INNOVATIONS (SI) CFO in this Form 4?

Yes. The filing shows an open-market purchase of 2,000 common shares of SHOULDER INNOVATIONS at $15.00 per share on March 13, 2026, classified under transaction code “P.”

How do the SHOULDER INNOVATIONS (SI) CFO’s stock options vest?

The stock option referenced in the filing vests in 31 equal monthly increments on the last day of each calendar month, beginning on March 31, 2025, according to the disclosed footnote.

Does the SHOULDER INNOVATIONS (SI) Form 4 show any insider share sales?

No insider sales are reported. The filing shows a derivative exercise of options for 13,264 shares and a purchase of 2,000 common shares, with no sale transactions disclosed in this Form 4.